Evidence map›Paper›PMID 28238852›Full record

ArticleRegulatory toxicology and pharmacology : RTP2017

The use of charcoal in modified cigarette filters for mainstream smoke carbonyl reduction.

Julie A Morabito, Matthew R Holman, Yan S Ding, Xizheng Yan, Michele Chan, Dana Chafin, Jose Perez, Magaly I Mendez, Roberto Bravo Cardenas, Clifford Watson

Open access · greenAbstract read
In one paragraph

Article in Regulatory toxicology and pharmacology : RTP, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Julie A MorabitoU.S. Food and Drug Administration, United States.
Matthew R HolmanU.S. Food and Drug Administration, United States.
Yan S DingCenters for Disease Control and Prevention, United States.
Xizheng YanCenters for Disease Control and Prevention, United States.
Michele ChanCenters for Disease Control and Prevention, United States.
Dana ChafinCenters for Disease Control and Prevention, United States.
Jose PerezCenters for Disease Control and Prevention, United States.
Magaly I MendezCenters for Disease Control and Prevention, United States.
Roberto Bravo CardenasCenters for Disease Control and Prevention, United States.
Clifford WatsonCenters for Disease Control and Prevention, United States.
Centers for Disease Control and Prevention · USUnited States Food and Drug Administration · US

Funding

Intramural CDC HHS CC999999Intramural FDA HHS FD999999
6 · The paper itself

Abstract

Carbonyls are harmful and potentially harmful constituents (HPHCs) in mainstream cigarette smoke (MSS). Carbonyls, including formaldehyde and acrolein, are carcinogenic or mutagenic in a dose-dependent manner. Past studies demonstrate significant reduction of HPHCs by charcoal filtration. However, limits of charcoal filtration and cigarette design have not yet been investigated in a systematic manner. Objective data is needed concerning the feasibility of HPHC reduction in combustible filtered cigarettes. This systematic study evaluates the effect of charcoal filtration on carbonyl reduction in MSS. We modified filters of ten popular cigarette products with predetermined quantities (100-400 mg) of charcoal in a plug-space-plug configuration. MSS carbonyls, as well as total particulate matter, tar, nicotine, carbon monoxide (TNCO), and draw resistance were quantified. Significant carbonyl reductions were observed across all cigarette products as charcoal loading increased. At the highest charcoal loadings, carbonyls were reduced by nearly 99%. Tar and nicotine decreased modestly (<20%) compared to reductions in carbonyls. Increased draw resistance was significant at only the highest charcoal loadings. This work addresses information gaps in the science base that can inform the evaluation of charcoal filtration as an available technological adaptation to cigarette design which reduces levels of carbonyls in MSS.

Indexed as

CharcoalSmokeTobacco ProductsAcroleinCarcinogensFiltrationFormaldehydeMutagensNicotineAcroleinCarcinogensCharcoalFormaldehydeMutagensNicotineSmokeCarbonylCharcoalCigaretteFiltrationHPHCRisk-reductionSmoke constituentsTechnologyTobacco

Identifiers

PMID28238852
PMCPMC5448414
OpenAlexW2590725572

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.